"Designing Growth Strategies is in our DNA"
Hypophosphatasia is a rare genetic disorder that affects the development of bones and teeth. Hypophosphatasia weakens the bones in the body and causes skeletal abnormalities. Hypophosphatasia is also called deficiency of alkaline phosphatase or phosphoethanolaminuria. The symptoms of hypophosphatasia vary widely. Affected infants are born with short limbs, respiratory problems, abnormally shaped chest, and soft skull bones. Symptoms that are identified in children and adult patients are less severe than those that appear in infants.
Current treatment of hypophosphatasia includes use of Asfotase alfa which has been approved by the Food and Drug Administration in 2015. Asfotase alfa is the first approved medication for the treatment of perinatal, infantile, and juvenile-onset hypophosphatasia. Asfotase alfa is a recombinant human alkaline phosphatase available for long term enzyme replacement to treat the bone manifestation of the disease. Another treatment is used to improve the symptoms of hypophosphatasia includes drugs like NSAIDs and Vitamin B6.
Research Institutes and pharmaceutical companies have focussed on studying and developing new methods for the treatment of hypophosphatasia. For instance; Asfotase alfa is being studied by Alexion Pharmaceuticals is in phase 2 of clinical trials for the study to evaluate its pharmacokinetic and pharmacodynamics in adult participants with pediatric-onset hypophosphatasia.
To get details on market share, speak to analyst
Currently, more than 50% of the pipeline candidates for hypophosphatasia are in phase 2 of the clinical trials. Majority of the studies is being sponsored by the pharmaceutical companies.
The report on ‘Hypophosphatasia– Pipeline Review, 2019’ provides a comprehensive overview of the drugs that are in the R&D pipeline by indication or molecule for hypophosphatasia. The report provides a thorough analysis of the distribution of the pipeline products by clinical trial stage, indication, company, therapy area and details such as clinical trial stage, sponsor, description on every product in the pipeline. Products in the preclinical and clinical stage along with dormant & discontinued pipeline candidates are included in the report. The report also covers additional insights such as epidemiology overview and current market scenario for hypophosphatasia.
The report on ‘Hypophosphatasia – Pipeline Review, 2019’, which is built by following a robust research methodology involving primary interviews and desk research, provides a complete overview of the R&D activity and pipeline products to assist companies in developing growth strategies and identifying emerging players.
“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”- One of the Leading Food Companies in Germany
“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”- Intuitive Surgical
“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”- Major Food Company in Japan
“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”- Ziering Medical
“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”- Major Manufacturer of Precision Machine Parts in India
“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”- Hewlett-Packard
“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”- Global Management Consulting Firm